Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Alibaba
BABA
|
+$408M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$292M |
| 4 |
Gilead Sciences
GILD
|
+$218M |
| 5 |
Ford
F
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.37B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.18B |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$619M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Booking.com
BKNG
|
+$406M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.56% |
| 2 | Technology | 2.53% |
| 3 | Consumer Discretionary | 2.02% |
| 4 | Financials | 1.63% |
| 5 | Healthcare | 1.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JO
3676
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
| $3.07M | ﹤0.01% |
100,660
-72,420
| -42% | -$2.56M |
|
3677
W.R. Berkley
WRB
$25.4B
| $3.06M | ﹤0.01% |
201,798
+105,891
| +110% | +$1.59M |
|
3678
CALL
BioCryst Pharmaceuticals
BCRX
$2.51B
| $3.06M | ﹤0.01% |
251,700
-21,600
| -8% | -$239K |
|
3679
DTE Energy
DTE
$28.3B
| $3.06M | ﹤0.01% |
41,604
-2,772
| -6% | -$192K |
|
3680
Ericsson
ERIC
$32.5B
| $3.06M | ﹤0.01% |
252,609
-204,770
| -45% | -$2.47M |
|
|
WPZ
3681
DELISTED
Williams Partners L.P.
WPZ
| $3.06M | ﹤0.01% |
59,847
+49,197
| +462% | +$2.78M |
|
3682
ProShares Investment Grade-Interest Rate Hedged
IGHG
$343M
| $3.06M | ﹤0.01% |
+39,510
| New | +$3.1M |
|
|
SYNT
3683
DELISTED
Syntel Inc
SYNT
| $3.06M | ﹤0.01% |
67,931
+7,321
| +12% | +$321K |
|
|
CLGX
3684
CALL
DELISTED
Corelogic, Inc.
CLGX
| $3.05M | ﹤0.01% |
96,600
+56,800
| +143% | +$1.73M |
|
3685
Boston Beer
SAM
$1.88B
| $3.05M | ﹤0.01% |
10,537
-10,335
| -50% | -$2.62M |
|
|
SPLK
3686
DELISTED
Splunk Inc
SPLK
| $3.05M | ﹤0.01% |
51,734
-114,223
| -69% | -$7.01M |
|
3687
iShares Government/Credit Bond ETF
GBF
$128M
| $3.05M | ﹤0.01% |
+26,670
| New | +$3.03M |
|
3688
State Street SPDR Portfolio TIPS ETF
SPIP
$1.02B
| $3.05M | ﹤0.01% |
108,948
+53,288
| +96% | +$1.5M |
|
|
WWE
3689
PUT
DELISTED
World Wrestling Entertainment
WWE
| $3.05M | ﹤0.01% |
246,900
-357,200
| -59% | -$4.48M |
|
3690
ProShares Ultra Dow30
DDM
$585M
| $3.04M | ﹤0.01% |
271,032
+119,916
| +79% | +$1.28M |
|
|
ARRY
3691
PUT
DELISTED
Array Biopharma Inc
ARRY
| $3.04M | ﹤0.01% |
642,900
+533,900
| +490% | +$2.11M |
|
3692
Affiliated Managers Group
AMG
$9.59B
| $3.04M | ﹤0.01% |
14,319
+2,625
| +22% | +$521K |
|
|
IMPV
3693
DELISTED
Imperva, Inc.
IMPV
| $3.04M | ﹤0.01% |
61,457
-215,234
| -78% | -$8.62M |
|
3694
CALL
Ametek
AME
$54.2B
| $3.04M | ﹤0.01% |
57,700
-20,900
| -27% | -$1.06M |
|
|
BPL
3695
PUT
DELISTED
Buckeye Partners, L.P.
BPL
| $3.03M | ﹤0.01% |
40,100
-5,100
| -11% | -$393K |
|
|
AL
3696
CALL
DELISTED
Air Lease Corp
AL
| $3.03M | ﹤0.01% |
88,300
-37,000
| -30% | -$1.3M |
|
3697
iShares US Medical Devices ETF
IHI
$3.41B
| $3.03M | ﹤0.01% |
160,746
-33,342
| -17% | -$602K |
|
3698
UBS Group
UBS
$168B
| $3.03M | ﹤0.01% |
+177,535
| New | +$3.04M |
|
3699
iShares Expanded Tech Sector ETF
IGM
$10.6B
| $3.03M | ﹤0.01% |
+178,164
| New | +$2.94M |
|
3700
Progress Software
PRGS
$1.84B
| $3.02M | ﹤0.01% |
111,874
+73,274
| +190% | +$1.9M |
|
Similar funds
Jeff Yass's Q4 2014 Portfolio in Review
As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jeff Yass's Q4 2014 filing shows 1,370 new, 3,710 increased, 4,352 reduced and 1,178 closed positions. Its largest new stake was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.37B.
By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, up from 87% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
- Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
- Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
- Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
- Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
- Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.
Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.